Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wenjing Tongluo Gao (温经通络膏) is a Traditional Chinese Medicine (TCM) topical paste developed by Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine. It is formulated to treat musculoskeletal conditions, specifically early and middle-stage knee osteoarthritis. The preparation follows the TCM therapeutic principle of "warming the meridians and unblocking the collaterals" (Wenjing Tongluo), which is intended to alleviate pain, reduce inflammation, and improve local blood circulation in affected joints. It is typically applied topically to the skin over the joint and is currently being evaluated in clinical trials for its efficacy in managing symptoms of joint degeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on wenjing tongluo gao.